Trials of oral bovine and rhesus rotavirus vaccines in Finland: A historical account and present status

Archives of Virology, Supplement

Volumn 1996, Issue 12, 1996, Pages 177-186

  Vesikari, T ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER; ORAL POLIOMYELITIS VACCINE; VIRUS VACCINE;

ANIMAL; ARTICLE; BREAST MILK; CATTLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FINLAND; HUMAN; IMMUNOLOGY; LACTOBACILLUS CASEI; MACACA; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; ROTAVIRUS; VIROLOGY; VIRUS INFECTION;

ADMINISTRATION, ORAL; ANIMALS; BUFFERS; CATTLE; CHILD; DOUBLE-BLIND METHOD; FINLAND; HUMANS; LACTOBACILLUS CASEI; MACACA MULATTA; MILK, HUMAN; POLIOVIRUS VACCINE, ORAL; ROTAVIRUS; ROTAVIRUS INFECTIONS; VIRAL VACCINES;

EID: 0030339678     PISSN: 09391983     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-7091-6553-9_19     Document Type: Article

References (35)

1. Bernstein DI, Glass RI, Rodgers G, Davidson BL, Sack DA, for the US Rotavirus Vaccine Efficacy Group (1995) Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. JAMA 273: 1191-1196
2. Bernstein DI, Smith VE, Sander DS, Pax KA, Schiff GM, Ward RL (1990) Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis 162: 1055-1062
3. Ceyhan M, Kanra G, Seçmeer G, Midthun K, Davidson BL, Zito ET, Vesikari T (1993) Take of rhesus-human reassortant tetravalent rotavirus vaccine in breast-fed infants. Acta Paediatr 82: 223-227
4. Chiba S, Yokoyama T, Nakata S, Morita Y, Urasawa T, Taniguchi K, Urasawa S, Nakao T (1986) Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancet 2: 417-421
5. Clark HF, Borian FE, Plotkin SA (1990) Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC 3. J Infect Dis 161: 1099-1104
6. Delem A, Lobmann M, Zygraich N (1984) A bovine rotavirus developed as a candicate vaccine for use in humans. J Biol Standard 12: 443-445
7. DeMol P, Zissis G, Butzler J-P, Mutwewingabo A, André FE (1986) Failure of live attenuated oral rotavirus vaccine. Lancet 2: 108
8. Georges-Courbot MC, Monges J, Siopathis MR, Roungon JB, Gresenguet G, Bellec L, Bouquety JC, Lanckriet C, Cadoz M, Hessel L, Gouvea V, Clark F, Georges AJ (1991) Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa. Res Virol 142: 405-411
9. Giammanco G, De Grandi V, Lupo L, Mistretta A, Pignato S, Teuween D, Bogaerst H, Andre FE (1988) Interference of oral poliovirus vaccine on RIT 4237 oral rotavirus vaccine. Eur J Epidemiol 4: 121-123
10. Hanlon P, Hanlon L, Marsh V, Byass P, Shenton F, Hassan-King M, Jobe O, Sillah H, Hayes R, M'Boge BH, Whittle HC, Greenwood BM (1987) A trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian children. Lancet 2: 1342-1345
11. Ho M-S, Floyd RL, Glass RI, Pallansch MA, Jones B, Hamby B, Woods P, Penaranda ME, Kapikian AZ, Bohan G, Wilcox WD, Blumberg R (1989) Simultaneous administration of rhesus rotavirus vaccine and oral poliovirus vaccine: immunogenicity and reactogenicity. Pediatr Infect Dis J 8: 692-996
12. Ing DJ, Glass RI, Woods PA, Simonetti M, Pallansch MA, Wilcox WD, Davidson BL, Sievert AJ (1991) Immunogenicity of tetravalent rhesus rotavirus vaccine administered with buffer and oral poliovirus vaccine. Am J Dis Child 145: 892-897
13. Isolauri E, Joensuu J, Suomalainen H, Luomala M, Vesikari T (1995) Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 13: 310-312
14. Lanata CF, Black RE, del Aguila R, Gil A, Verastegui H, Gerna G, Flores J, Kapikian AZ, André FE (1989) Protection of Peruvian children gainst rotavirus diarrhea of specific serotypesby the RIT 4237 attenuated bovine rotavirus vaccine. J Infect Dis 159: 452-459
15. Migasena S, Simasathien S, Samakoses R, Pitisuttitham P, Sangaroon P, van Steenis G, Beuvery EC, Bugg H, Bishop R, Davidson BL, Vesikari T (1995) Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants. Vaccine 13: 168-174
16. Pichichero ME (1990) Effect of breast-feeding on oral rotavirus vaccine seroconversion;a metaanalysis. J Infect Dis 162: 753-755
17. Ruuska T, Vesikari T, Delem A, André FE, Beards GM, Flewett TH (1990) Evaluation of RIT 4237 bovine rotavirus vaccine in newborn infants: Correlation of vaccine efficacy to season of birth in relation to rotavirus epidemic period. Scand J Infect Dis 22: 269-278
18. Ruuska T, Vesikari T (1990) Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis 20: 259-267
19. Treanor JJ, Clark F, Pichichero M, Christy C, Gouvea V, Shrager D, Palazzo S, Offit P (1995) Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants. Pediatr Infect Dis J 14: 301-307
20. Vesikari T (1993) Clinical trials of live oral rotavirus vaccines: the Finnish experience. Vaccine 11: 255-261
21. Vesikari T, Isolauri E, Delem A, D'Hondt E, André FE, Beards GM, Flewett TH (1985) Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. J Pediatr 107: 189-194
22. Vesikari T, Isolauri E, Delem A, D'Hondt E, André FE, Zissis G (1983) Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children. Lancet 2: 807-811
23. Vesikari T, Isolauri E, D'Hondt E, Delem A, André FE (1984) Increased "take" rate of oral rotavirus vaccine in infants after milk feeding. Lancet ii: 700
24. Vesikari T, Isolauri E, D'Hondt E, Delem A, André FE, Zissis G (1984) Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet 1: 977-981
25. Vesikari T, Kapikian AZ, Delem A, Zissis G (1986) A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children. J Infect Dis 153: 832-839
26. Vesikari T, Rautanen T, Varis T, Beards GM, Kapikian AZ (1990) Clinical trial of rhesus rotavirus candidate vaccine (strain MMU 18006) in children vaccination between 2 and 5 months of age. Am J Dis Child 14: 285-289
27. Vesikari T, Ruuska T, Delem A, André FE, Beards GM, Flewett TH (1991) Efficacy of two doses of RIT 4237 bovine rotavirus vaccine for prevention of rotavirus diarrhoea. Acta Paediatr Scand 80: 173-180
28. Vesikari T, Ruuska T, Delem A, André FE (1987) Neonatal rotavirus vaccination with RIT 4237 bovine rotavirus vaccine: a preliminary report. Pediatr Infect Dis J 6: 164-169
29. Vesikari T, Ruuska T, Delem A, André FE (1986) Oral rotavirus vaccination in breast- and bottle-fed infants aged 6 to 12 months. Acta Paediatr Scand 75: 573-578
30. Vesikari T, Ruuska T, Green K, Flores J, Kapikian AZ (1992) Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity. Pediatr Infect Dis J 11: 535-542
31. Vesikari T, Varis T, Green J, Kapikian AZ (1991) Immunogenicity and safety of rhesus-human reassortant vaccines with serotype 1 or 2 VP7 specificity. Vaccine 9: 334-339
32. Vodopija I, Baklaic Z, Vlatkovic R, Bogaerts H, Delem A, André FE (1986) Combined vaccination with live oral poliovaccine and the bovine rotavirus RIT 4237 strain. Vaccine 4: 233-236
33. Wilde J, Eiden J, Willoughby J (1991) Improved detection of rotavirus shedding by polymerase chain reaction. Lancet 337: 323-326
34. Yosukawa M, Nakagomi O, Dobayaski Y (1990) Rotavirus induces proliferative response and augments non-specific cytotoxic activity of lymphocytes in humans. Clin Exp Immunol 80: 49-55
35. Zheng BJ, Lo SKF, Tam JSL, Lo M, Yeung CY, Ng MH (1989) Prospective study of community acquired rotavirus infection. J Clin Microbiol 27: 1939-1945